Role of secreted factors in the regulation of hematopoietic stem cells by the bone marrow microenvironment

Frontiers in Bioscience

Volumn 17, Issue 3, 2012, Pages 876-891

  Kaur Bollinger, Pawandeep ^a   Gotze, Katharina S ^a   Oostendorp, Robert A J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone marrow homeostasis; Bone marrow niche; Cell communication; Hematopoiesis; Microenvironment; Review; Soluble factors; Stem cell adhesion; Stem cell homing; Stem cell quiescence

Indexed keywords

EID: 84860346840     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3962     Document Type: Article

References (163)

1. T M Dexter, T D Allen and L G Lajtha: Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol, 91(3), 335-44 (1977). (Pubitemid 8112206)
2. T M Dexter, E G Wright, F Krizsa and L G Lajtha: Regulation of haemopoietic stem cell proliferation in long term bone marrow cultures. Biomedicine, 27(9-10), 344-9 (1977). (Pubitemid 8271852)
3. S Palani and C A Sarkar: Integrating extrinsic and intrinsic cues into a minimal model of lineage commitment for hematopoietic progenitors. PLoS Comput Biol, 5(9), e1000518 (2009).
4. J J Trentin: Determination of bone marrow stem cell differentiation by stromal hemopoietic inductive microenvironments (HIM). Am J Pathol, 65(3), 621-8 (1971).
5. R Schofield: The relationship between the spleen colonyforming cell and the haemopoietic stem cell. Blood Cells, 4(1-2), 7-25 (1978). (Pubitemid 8376317)
6. L M Calvi, G B Adams, K W Weibrecht, J M Weber, D P Olson, M C Knight, R P Martin, E Schipani, P Divieti, F R Bringhurst, L A Milner, H M Kronenberg and D T Scadden: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425(6960), 841- 6 (2003). (Pubitemid 37351468)
7. J Zhang, C Niu, L Ye, H Huang, X He, W G Tong, J Ross, J Haug, T Johnson, J Q Feng, S Harris, L M Wiedemann, Y Mishina and L Li: Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 425(6960), 836-41 (2003). (Pubitemid 37351467)
8. J M Butler, D J Nolan, E L Vertes, B Varnum-Finney, H Kobayashi, A T Hooper, M Seandel, K Shido, I A White, M Kobayashi, L Witte, C May, C Shawber, Y Kimura, J Kitajewski, Z Rosenwaks, I D Bernstein and S Rafii: Endothelial cells are essential for the selfrenewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell, 6(3), 251-64.
9. Y Katayama, M Battista, W M Kao, A Hidalgo, A J Peired, S A Thomas and P S Frenette: Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell, 124(2), 407-21 (2006). (Pubitemid 43121987)
10. D C Kirouac, G J Madlambayan, M Yu, E A Sykes, C Ito and P W Zandstra: Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol, 5, 293 (2009).
11. W Li, S A Johnson, W C Shelley and M C Yoder: Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp Hematol, 32(12), 1226-37 (2004). (Pubitemid 39601128)
12. J E Brandt, A M Bartholomew, J D Fortman, M C Nelson, E Bruno, L M Chen, J V Turian, T A Davis, J P Chute and R Hoffman: Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood, 94(1), 106-13 (1999). (Pubitemid 29300139)
13. S T Avecilla, K Hattori, B Heissig, R Tejada, F Liao, K Shido, D K Jin, S Dias, F Zhang, T E Hartman, N R Hackett, R G Crystal, L Witte, D J Hicklin, P Bohlen, D Eaton, D Lyden, F de Sauvage and S Rafii: Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med, 10(1), 64-71 (2004). (Pubitemid 38524700)
14. A Wilson, E Laurenti, G Oser, R C van der Wath, W Blanco-Bose, M Jaworski, S Offner, C F Dunant, L Eshkind, E Bockamp, P Lio, H R Macdonald and A Trumpp: Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell, 135(6), 1118- 29 (2008).
15. J L Abkowitz, A E Robinson, S Kale, M W Long and J Chen: Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood, 102(4), 1249-53 (2003). (Pubitemid 36988029)
16. T Sugiyama, H Kohara, M Noda and T Nagasawa: Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity, 25(6), 977-88 (2006). (Pubitemid 44894948)
17. S Mendez-Ferrer, T V Michurina, F Ferraro, A R Mazloom, B D Macarthur, S A Lira, D T Scadden, A Ma'ayan, G N Enikolopov and P S Frenette: Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 466(7308), 829-34 (2010).
18. K E Poole and J Reeve: Parathyroid hormone - a bone anabolic and catabolic agent. Curr Opin Pharmacol, 5(6), 612-7 (2005). (Pubitemid 41614461)
19. D C Goldman, A S Bailey, D L Pfaffle, A Al Masri, J L Christian and W H Fleming: BMP4 regulates the hematopoietic stem cell niche. Blood, 114(20), 4393-401 (2009).
20. C E Muller-Sieburg and E Deryugina: The stromal cells' guide to the stem cell universe. Stem Cells, 13(5), 477-86 (1995).
21. R A Oostendorp, K N Harvey, N Kusadasi, M F de Bruijn, C Saris, R E Ploemacher, A L Medvinsky and E A Dzierzak: Stromal cell lines from mouse aorta-gonadsmesonephros subregions are potent supporters of hematopoietic stem cell activity. Blood, 99(4), 1183-9 (2002). (Pubitemid 34547069)
22. R A Oostendorp, C Robin, C Steinhoff, S Marz, R Brauer, U A Nuber, E A Dzierzak and C Peschel: Longterm maintenance of hematopoietic stem cells does not require contact with embryo-derived stromal cells in cocultures. Stem Cells, 23(6), 842-51 (2005). (Pubitemid 40791799)
23. K C Weisel, Y Gao, J H Shieh and M A Moore: Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis. Exp Hematol, 34(11), 1505-16 (2006). (Pubitemid 44548113)
24. J P Chute, A A Saini, D J Chute, M R Wells, W B Clark, D M Harlan, J Park, M K Stull, C Civin and T A Davis: Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. Blood, 100(13), 4433-9 (2002). (Pubitemid 35429682)
25. K Thalmeier, P Meissner, G Reisbach, L Hultner, B T Mortensen, A Brechtel, R A Oostendorp and P Dormer: Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines. Exp Hematol, 24(1), 1-10 (1996). (Pubitemid 26041770)
26. L Graf, M Iwata and B Torok-Storb: Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a. Blood, 100(4), 1509- 11 (2002). (Pubitemid 34864317)
27. J P Chute, G G Muramoto, J Fung and C Oxford: Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells. Blood, 105(2), 576-83 (2005). (Pubitemid 40070739)
28. R A Oostendorp, K Harvey and E A Dzierzak: Generation of murine stromal cell lines: models for the microenvironment of the embryonic mouse aorta-gonadsmesonephros region. Methods Mol Biol, 290, 163-72 (2005).
29. O Ohneda, K Ohneda, H Nomiyama, Z Zheng, S A Gold, F Arai, T Miyamoto, B E Taillon, R A McIndoe, R A Shimkets, D A Lewin, T Suda and L A Lasky: WECHE: a novel hematopoietic regulatory factor. Immunity, 12(2), 141-50 (2000). (Pubitemid 30398628)
30. K A Moore, B Pytowski, L Witte, D Hicklin and I R Lemischka: Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factorlike repeat motifs. Proc Natl Acad Sci USA, 94(8), 4011-6 (1997). (Pubitemid 27180490)
31. H Ueno, M Sakita-Ishikawa, Y Morikawa, T Nakano, T Kitamura and M Saito: A stromal cellderived membrane protein that supports hematopoietic stem cells. Nat Immunol, 4(5), 457-63 (2003). (Pubitemid 36592438)
32. J A Hackney, P Charbord, B P Brunk, C J Stoeckert, I R Lemischka and K A Moore: A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci USA, 99(20), 13061-6 (2002).
33. J Renstrom, R Istvanffy, K Gauthier, A Shimono, J Mages, A Jardon-Alvarez, M Kroger, M Schiemann, D H Busch, I Esposito, R Lang, C Peschel and R A Oostendorp: Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells. Cell Stem Cell, 5(2), 157- 67 (2009).
34. I Maillard, U Koch, A Dumortier, O Shestova, L Xu, H Sai, S E Pross, J C Aster, A Bhandoola, F Radtke and W S Pear: Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell, 2(4), 356-66 (2008). (Pubitemid 351455243)
35. G Jeannet, M Scheller, L Scarpellino, S Duboux, N Gardiol, J Back, F Kuttler, I Malanchi, W Birchmeier, A Leutz, J Huelsken and W Held: Long-term, multilineage hematopoiesis occurs in the combined absence of betacatenin and gamma-catenin. Blood, 111(1), 142-9 (2008).
36. U Koch, A Wilson, M Cobas, R Kemler, H R Macdonald and F Radtke: Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis. Blood, 111(1), 160-4 (2008).
37. G Karlsson, U Blank, J L Moody, M Ehinger, S Singbrant, C X Deng and S Karlsson: Smad4 is critical for self-renewal of hematopoietic stem cells. J Exp Med, 204(3), 467-74 (2007). (Pubitemid 46457070)
38. K W Orford and D T Scadden: Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet, 9(2), 115-28 (2008).
39. L I Zon: Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature, 453(7193), 306-13 (2008). (Pubitemid 351693136)
40. M Ohtsubo, S Yasunaga, Y Ohno, M Tsumura, S Okada, N Ishikawa, K Shirao, A Kikuchi, H Nishitani, M Kobayashi and Y Takihara: Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoietic stem cell activity. Proc Natl Acad Sci USA, 105(30), 10396-401 (2008).
41. F Arai, A Hirao, M Ohmura, H Sato, S Matsuoka, K Takubo, K Ito, G Y Koh and T Suda: Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell, 118(2), 149-61 (2004). (Pubitemid 38962572)
42. J Miyauchi, C A Kelleher, G G Wong, Y C Yang, S C Clark, S Minkin, M D Minden and E A McCulloch: The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture. Leukemia, 2(6), 382-7 (1988).
43. R Henschler, W Brugger, T Luft, T Frey, R Mertelsmann and L Kanz: Maintenance of transplantation potential in ex vivo expanded CD34(+)-selected human peripheral blood progenitor cells. Blood, 84(9), 2898-903 (1994).
44. P W Zandstra, E Conneally, A L Petzer, J M Piret and C J Eaves: Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA, 94(9), 4698-703 (1997).
45. J Audet, C L Miller, C J Eaves and J M Piret: Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis. Biotechnol Bioeng, 80(4), 393-404 (2002). (Pubitemid 35230933)
46. K Ikuta and I L Weissman: Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA, 89(4), 1502-6 (1992).
47. V C Broudy: Stem cell factor and hematopoiesis. Blood, 90(4), 1345-64 (1997). (Pubitemid 27355406)
48. S Mendez-Ferrer, D Lucas, M Battista and P S Frenette: Haematopoietic stem cell release is regulated by circadian oscillations. Nature, 452(7186), 442-7 (2008). (Pubitemid 351450836)
49. B Nervi, D C Link and J F DiPersio: Cytokines and hematopoietic stem cell mobilization. J Cell Biochem, 99(3), 690-705 (2006). (Pubitemid 44521989)
50. D G Kent, B J Dykstra, J Cheyne, E Ma and C J Eaves: Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells. Blood, 112(3), 560-7 (2008).
51. D Kent, M Copley, C Benz, B Dykstra, M Bowie and C Eaves: Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway. Clin Cancer Res, 14(7), 1926-30 (2008). (Pubitemid 351551100)
52. R A Oostendorp, S Gilfillan, A Parmar, M Schiemann, S Marz, M Niemeyer, S Schill, E Hammerschmid, V R Jacobs, C Peschel and K S Gotze: Oncostatin M-mediated regulation of KIT-ligand-induced extracellular signalregulated kinase signaling maintains hematopoietic repopulating activity of Lin-CD34+CD133+ cord blood cells. Stem Cells, 26(8), 2164-72 (2008).
53. J L Christensen and I L Weissman: Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA, 98(25), 14541-6 (2001). (Pubitemid 33121428)
54. K Mackarehtschian, J D Hardin, K A Moore, S Boast, S P Goff and I R Lemischka: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity, 3(1), 147-61 (1995).
55. E Sitnicka, N Buza-Vidas, S Larsson, J M Nygren, K Liuba and S E Jacobsen: Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood, 102(3), 881-6 (2003). (Pubitemid 36917779)
56. K Masson and L Ronnstrand: Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signal, 21(12), 1717-26 (2009).
57. D Schmidt-Arras, S A Bohmer, S Koch, J P Muller, L Blei, H Cornils, R Bauer, S Korasikha, C Thiede and F D Bohmer: Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. Blood, 113(15), 3568-76 (2009).
58. K S Gotze, M Schiemann, S Marz, V R Jacobs, G Debus, C Peschel and R A Oostendorp: CD133-enriched CD34(-) (CD33/CD38/CD71)(-) cord blood cells acquire CD34 prior to cell division and hematopoietic activity is exclusively associated with CD34 expression. Exp Hematol, 35(9), 1408-14 (2007). (Pubitemid 47302586)
59. K Masson, E Heiss, H Band and L Ronnstrand: Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation. Biochem J, 399(1), 59-67 (2006). (Pubitemid 44505407)
60. B Sargin, C Choudhary, N Crosetto, M H Schmidt, R Grundler, M Rensinghoff, C Thiessen, L Tickenbrock, J Schwable, C Brandts, B August, S Koschmieder, S R Bandi, J Duyster, W E Berdel, C Muller-Tidow, I Dikic and H Serve: Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood, 110(3), 1004-12 (2007). (Pubitemid 47267440)
61. X M Dai, G R Ryan, A J Hapel, M G Dominguez, R G Russell, S Kapp, V Sylvestre and E R Stanley: Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood, 99(1), 111-20 (2002).
62. M A Rieger, P S Hoppe, B M Smejkal, A C Eitelhuber and T Schroeder: Hematopoietic cytokines can instruct lineage choice. Science, 325(5937), 217-8 (2009).
63. S Davis, T H Aldrich, P F Jones, A Acheson, D L Compton, V Jain, T E Ryan, J Bruno, C Radziejewski, P C Maisonpierre and G D Yancopoulos: Isolation of angiopoietin- 1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87(7), 1161-9 (1996). (Pubitemid 27010100)
64. B Sacchetti, A Funari, S Michienzi, S Di Cesare, S Piersanti, I Saggio, E Tagliafico, S Ferrari, P G Robey, M Riminucci and P Bianco: Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 131(2), 324-36 (2007). (Pubitemid 47592917)
65. H Huang, A Bhat, G Woodnutt and R Lappe: Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer, 10(8), 575-85.
66. C C Zhang, M Kaba, G Ge, K Xie, W Tong, C Hug and H F Lodish: Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med, 12(2), 240-5 (2006). (Pubitemid 43214753)
67. S Chou and H F Lodish: Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells. Proc Natl Acad Sci USA, 107(17), 7799-804.
68. J Zheng, H Huynh, M Umikawa, R Silvany and C C Zhang: Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Blood (2010).
69. P Papathanasiou, J L Attema, H Karsunky, N Hosen, Y Sontani, G F Hoyne, R Tunningley, S T Smale and I L Weissman: Self-renewal of the long-term reconstituting subset of hematopoietic stem cells is regulated by Ikaros. Stem Cells, 27(12), 3082-92 (2009).
70. S Lok, K Kaushansky, R D Holly, J L Kuijper, C E Lofton-Day, P J Oort, F J Grant, M D Heipel, S K Burkhead, J M Kramer and et al: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369(6481), 565-8 (1994). (Pubitemid 24192525)
71. K Kaushansky: Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders. Cytokine Growth Factor Rev, 17(6), 423-30 (2006). (Pubitemid 44793119)
72. H Qian, N Buza-Vidas, C D Hyland, C T Jensen, J Antonchuk, R Mansson, L A Thoren, M Ekblom, W S Alexander and S E Jacobsen: Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell, 1(6), 671-84 (2007). (Pubitemid 350215331)
73. H Yoshihara, F Arai, K Hosokawa, T Hagiwara, K Takubo, Y Nakamura, Y Gomei, H Iwasaki, S Matsuoka, K Miyamoto, H Miyazaki, T Takahashi and T Suda: Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell, 1(6), 685-97 (2007). (Pubitemid 350215333)
74. T Matsunaga, T Kato, H Miyazaki and M Ogawa: Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6. Blood, 92(2), 452-61 (1998).
75. M Yagi, K A Ritchie, E Sitnicka, C Storey, G J Roth and S Bartelmez: Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin. Proc Natl Acad Sci USA, 96(14), 8126-31 (1999). (Pubitemid 29328419)
76. K Carver-Moore, H E Broxmeyer, S M Luoh, S Cooper, J Peng, S A Burstein, M W Moore and F J de Sauvage: Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice Blood, 88(3), 803-8 (1996). (Pubitemid 26333299)
77. W S Alexander, A W Roberts, N A Nicola, R Li and D Metcalf: Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood, 87(6), 2162-70 (1996).
78. W S Alexander, A W Roberts, A B Maurer, N A Nicola, A R Dunn and D Metcalf: Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation. Stem Cells, 14 Suppl 1, 124-32 (1996). (Pubitemid 126687200)
79. S Kimura, A W Roberts, D Metcalf and W S Alexander: Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci USA, 95(3), 1195-200 (1998). (Pubitemid 28124935)
80. T Nishino, K Miyaji, N Ishiwata, K Arai, M Yui, Y Asai, H Nakauchi and A Iwama: Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL. Exp Hematol, 37(11), 1364-1377 e4 (2009).
81. J Seita, H Ema, J Ooehara, S Yamazaki, Y Tadokoro, A Yamasaki, K Eto, S Takaki, K Takatsu and H Nakauchi: Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci USA, 104(7), 2349-54 (2007). (Pubitemid 46391400)
82. A Bersenev, C Wu, J Balcerek and W Tong: Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest, 118(8), 2832-44 (2008).
83. S T Oh, E F Simonds, C Jones, M B Hale, Y Goltsev, K D Gibbs, Jr, J D Merker, J L Zehnder, G P Nolan and J Gotlib: Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood, 116(6), 988-92.
84. T Reya, A W Duncan, L Ailles, J Domen, D C Scherer, K Willert, L Hintz, R Nusse and I L Weissman: A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423(6938), 409-14 (2003). (Pubitemid 36626987)
85. D K Lee, R Nathan Grantham, A L Trachte, J D Mannion and C L Wilson: Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells. Biochem Biophys Res Commun, 347(1), 109-16 (2006). (Pubitemid 44015656)
86. S Malhotra and P W Kincade: Wnt-related molecules and signaling pathway equilibrium in hematopoiesis. Cell Stem Cell, 4(1), 27-36 (2009).
87. T C Luis, F Weerkamp, B A Naber, M R Baert, E F de Haas, T Nikolic, S Heuvelmans, R R De Krijger, J J van Dongen and F J Staal: Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood, 113(3), 546-54 (2009).
88. H Liang, Q Chen, A H Coles, S J Anderson, G Pihan, A Bradley, R Gerstein, R Jurecic and S N Jones: Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell, 4(5), 349- 60 (2003). (Pubitemid 37491096)
89. S M Buckley, F Ulloa-Montoya, D Abts, R A Oostendorp, E Dzierzak, S C Ekker and C M Verfaillie: Maintenance of HSC by Wnt5a secreting AGM-derived stromal cell line. Exp Hematol, (2010).
90. P Kirstetter, K Anderson, B T Porse, S E Jacobsen and C Nerlov: Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol, 7(10), 1048-56 (2006). (Pubitemid 44420649)
91. J Huang, Y Zhang, A Bersenev, W T O'Brien, W Tong, S G Emerson and P S Klein: Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. J Clin Invest, 119(12), 3519-29 (2009).
92. X Wu, M Yamamoto, S Akira and S C Sun: Regulation of hematopoiesis by the K63-specific ubiquitin-conjugating enzyme Ubc13. Proc Natl Acad Sci USA (2009).
93. M J Nemeth, K K Mak, Y Yang and D M Bodine: beta- Catenin expression in the bone marrow microenvironment is required for long-term maintenance of primitive hematopoietic cells. Stem Cells, 27(5), 1109-19 (2009).
94. J A Kim, Y J Kang, G Park, M Kim, Y O Park, H Kim, S H Leem, I S Chu, J S Lee, E H Jho and I H Oh: Identification of a stroma-mediated Wnt/beta-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche. Stem Cells, 27(6), 1318-29 (2009).
95. H E Fleming, V Janzen, C Lo Celso, J Guo, K M Leahy, H M Kronenberg and D T Scadden: Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell, 2(3), 274-83 (2008). (Pubitemid 351298592)
96. T Suda and F Arai: Wnt signaling in the niche. Cell, 132(5), 729-30 (2008). (Pubitemid 351312805)
97. F N Karanu, B Murdoch, L Gallacher, D M Wu, M Koremoto, S Sakano and M Bhatia: The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med, 192(9), 1365-72 (2000).
98. F N Karanu, L Yuefei, L Gallacher, S Sakano and M Bhatia: Differential response of primitive human CD34- and CD34+ hematopoietic cells to the Notch ligand Jagged- 1. Leukemia, 17(7), 1366-74 (2003). (Pubitemid 36857345)
99. B Varnum-Finney, L E Purton, M Yu, C Brashem- Stein, D Flowers, S Staats, K A Moore, I Le Roux, R Mann, G Gray, S Artavanis-Tsakonas and I D Bernstein: The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood, 91(11), 4084-91 (1998). (Pubitemid 28261969)
100. B Varnum-Finney, C Brashem-Stein and I D Bernstein: Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood, 101(5), 1784-9 (2003). (Pubitemid 36237574)
101. N Kaltz, J Ringe, C Holzwarth, P Charbord, M Niemeyer, V R Jacobs, C Peschel, T Haupl and R A Oostendorp: Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources. Exp Cell Res, 316(16), 2609-17.
102. S J Mancini, N Mantei, A Dumortier, U Suter, H R MacDonald and F Radtke: Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell selfrenewal and differentiation. Blood, 105(6), 2340-2 (2005). (Pubitemid 40387028)
103. T Mercher, M G Cornejo, C Sears, T Kindler, S A Moore, I Maillard, W S Pear, J C Aster and D G Gilliland: Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell, 3(3), 314-26 (2008).
104. Y W Kim, B K Koo, H W Jeong, M J Yoon, R Song, J Shin, D C Jeong, S H Kim and Y Y Kong: Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood, 112(12), 4628-38 (2008).
105. D N Haylock, B Williams, H M Johnston, M C Liu, K E Rutherford, G A Whitty, P J Simmons, I Bertoncello and S K Nilsson: Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells, 25(4).
106. M J Kiel, O H Yilmaz, T Iwashita, C Terhorst and S J Morrison: SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell, 121(7), 1109-21 (2005). (Pubitemid 40884400)
107. C Lo Celso, H E Fleming, J W Wu, C X Zhao, S Miake-Lye, J Fujisaki, D Cote, D W Rowe, C P Lin and D T Scadden: Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature, 457(7225), 92-6 (2009).
108. Y Xie, T Yin, W Wiegraebe, X C He, D Miller, D Stark, K Perko, R Alexander, J Schwartz, J C Grindley, J Park, J S Haug, J P Wunderlich, H Li, S Zhang, T Johnson, R A Feldman and L Li: Detection of functional haematopoietic stem cell niche using real-time imaging. Nature, 457(7225), 97-101 (2009).
109. T Nagasawa, S Hirota, K Tachibana, N Takakura, S Nishikawa, Y Kitamura, N Yoshida, H Kikutani and T Kishimoto: Defects of B-cell lymphopoiesis and bonemarrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 382(6592), 635-8 (1996). (Pubitemid 26268957)
110. X Yu, P Collin-Osdoby and P Osdoby: SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity. Connect Tissue Res, 44 Suppl 1, 79-84 (2003). (Pubitemid 36395426)
111. Y Nie, Y C Han and Y R Zou: CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med, 205(4), 777-83 (2008). (Pubitemid 351549877)
112. A Chabanon, C Desterke, E Rodenburger, D Clay, B Guerton, L Boutin, A Bennaceur-Griscelli, O Pierre-Louis, G Uzan, L Abecassis, M F Bourgeade, J J Lataillade and M C Le Bousse-Kerdiles: A cross-talk between stromal cellderived factor-1 and transforming growth factor-beta controls the quiescence/cycling switch of CD34(+) progenitors through FoxO3 and mammalian target of rapamycin Stem Cells, 26(12), 3150-61 (2008).
113. O Kollet, A Dar, S Shivtiel, A Kalinkovich, K Lapid, Y Sztainberg, M Tesio, R M Samstein, P Goichberg, A Spiegel, A Elson and T Lapidot: Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med, 12(6), 657-64 (2006). (Pubitemid 43865234)
114. N D Staudt, W K Aicher, H Kalbacher, S Stevanovic, A K Carmona, M Bogyo and G Klein: Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts. Haematologica, (2009).
115. M Jeong, Z H Piao, M S Kim, S H Lee, S Yun, H N Sun, S R Yoon, J W Chung, T D Kim, J H Jeon, J Lee, H N Kim, J Y Choi and I Choi: Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions. J Immunol, 183(4), 2495-505 (2009).
116. R Grundler, L Brault, C Gasser, A N Bullock, T Dechow, S Woetzel, V Pogacic, A Villa, S Ehret, G Berridge, A Spoo, C Dierks, A Biondi, S Knapp, J Duyster and J Schwaller: Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration. J Exp Med, 206(9), 1957-70 (2009).
117. S M Crean, J P Meneski, T G Hullinger, M J Reilly, E H DeBoever and R S Taichman: N-linked sialyated sugar receptors support haematopoietic cell-osteoblast adhesions. Br J Haematol, 124(4), 534-46 (2004). (Pubitemid 38230600)
118. R A Oostendorp and P Dormer: VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells. Leuk Lymphoma, 24(5-6), 423-35 (1997). (Pubitemid 27182199)
119. R A Oostendorp, E Spitzer, G Reisbach and P Dormer: Antibodies to the beta 1-integrin chain, CD44, or ICAM-3 stimulate adhesion of blast colony-forming cells and may inhibit their growth. Exp Hematol, 25(4), 345-9 (1997). (Pubitemid 27236660)
120. F J Antonawich, C S Melton, P Wu and J N Davis: Nesting and shredding behavior as an indicator of hippocampal ischemic damage. Brain Res, 764(1-2), 249- 52 (1997). (Pubitemid 27380664)
121. J P Levesque, D I Leavesley, S Niutta, M Vadas and P J Simmons: Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med, 181(5), 1805-15 (1995).
122. L Cui, V Ramsfjell, O J Borge, O P Veiby, S Lok and S E Jacobsen: Thrombopoietin promotes adhesion of primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-1: role of activation of very late antigen (VLA)-4 and VLA-5. J Immunol, 159(4), 1961-9 (1997). (Pubitemid 127484186)
123. L Yang, L Wang, H Geiger, J A Cancelas, J Mo and Y Zheng: Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow. Proc Natl Acad Sci USA, 104(12), 5091-6 (2007). (Pubitemid 47186181)
124. G Ghiaur, A Lee, J Bailey, J A Cancelas, Y Zheng and D A Williams: Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment Blood, 108(6), 2087-94 (2006). (Pubitemid 44395025)
125. F Guo, C S Velu, H L Grimes and Y Zheng: Rho GTPase Cdc42 is essential for B-lymphocyte development and activation. Blood, 114(14), 2909-16 (2009).
126. Y Jung, J Wang, J Song, Y Shiozawa, A Havens, Z Wang, Y X Sun, S G Emerson, P H Krebsbach and R S Taichman: Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood, 110(1), 82- 90 (2007). (Pubitemid 47026822)
127. C E Macsai, B K Foster and C J Xian: Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J Cell Physiol, 215(3), 578-87 (2008). (Pubitemid 351632678)
128. B O Williams and K L Insogna: Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res, 24(2), 171-8 (2009).
129. L Qin, P Qiu, L Wang, X Li, J T Swarthout, P Soteropoulos, P Tolias and N C Partridge: Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem, 278(22), 19723-31 (2003). (Pubitemid 36799158)
130. S Stier, Y Ko, R Forkert, C Lutz, T Neuhaus, E Grunewald, T Cheng, D Dombkowski, L M Calvi, S R Rittling and D T Scadden: Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med, 201(11), 1781-91 (2005). (Pubitemid 41002897)
131. A Aicher, O Kollet, C Heeschen, S Liebner, C Urbich, C Ihling, A Orlandi, T Lapidot, A M Zeiher and S Dimmeler: The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche. Circ Res, 103(8), 796-803 (2008).
132. K D Hausler, N J Horwood, Y Chuman, J L Fisher, J Ellis, T J Martin, J S Rubin and M T Gillespie: Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res, 19(11), 1873-81 (2004). (Pubitemid 41103439)
133. P V Bodine, W Zhao, Y P Kharode, F J Bex, A J Lambert, M B Goad, T Gaur, G S Stein, J B Lian and B S Komm: The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice Mol Endocrinol, 18(5), 1222-37 (2004). (Pubitemid 38591287)
134. G Bain, T Muller, X Wang and J Papkoff: Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun, 301(1), 84-91 (2003). (Pubitemid 36268851)
135. H B Kuiperij, M van Pel, K E de Rooij, R C Hoeben and W E Fibbe: Serpina1 (alpha1-AT) is synthesized in the osteoblastic stem cell niche. Exp Hematol, 37(5), 641-7 (2009).
136. Y Shen, I G Winkler, V Barbier, N A Sims, J Hendy and J P Levesque: Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo. PLoS One, 5(9).
137. M Kieslinger, S Hiechinger, G Dobreva, G G Consalez and R Grosschedl: Early B cell factor 2 regulates hematopoietic stem cell homeostasis in a cellnonautonomous manner. Cell Stem Cell, 7(4), 496-507.
138. S R Mayack and A J Wagers: Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood, 112(3), 519-31 (2008).
139. I G Winkler, N A Sims, A R Pettit, V Barbier, B Nowlan, F Helwani, I J Poulton, N van Rooijen, K A Alexander, L J Raggatt and J P Levesque: Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSC. Blood.
140. T Holyoake, X Jiang, C Eaves and A Eaves: Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood, 94(6), 2056-64 (1999). (Pubitemid 29430422)
141. Y Guan, B Gerhard and D E Hogge: Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood, 101(8), 3142-9 (2003). (Pubitemid 36858008)
142. O H Yilmaz, R Valdez, B K Theisen, W Guo, D O Ferguson, H Wu and S J Morrison: Pten dependence distinguishes haematopoietic stem cells from leukaemiainitiating cells. Nature, 441(7092), 475-82 (2006). (Pubitemid 44050144)
143. L Zhang, K S Kendler and X Chen: Association of the phosphatase and tensin homolog gene (PTEN) with smoking initiation and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet, 141B(1), 10-4 (2006). (Pubitemid 43062536)
144. R A Rupec, F Jundt, B Rebholz, B Eckelt, G Weindl, T Herzinger, M J Flaig, S Moosmann, G Plewig, B Dorken, I Forster, R Huss and K Pfeffer: Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity, 22(4), 479-91 (2005). (Pubitemid 40545113)
145. C R Walkley, J M Shea, N A Sims, L E Purton and S H Orkin: Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell, 129(6), 1081-95 (2007). (Pubitemid 46908695)
146. C R Walkley, G H Olsen, S Dworkin, S A Fabb, J Swann, G A McArthur, S V Westmoreland, P Chambon, D T Scadden and L E Purton: A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell, 129(6), 1097-110 (2007). (Pubitemid 46908696)
147. M H Raaijmakers, S Mukherjee, S Guo, S Zhang, T Kobayashi, J A Schoonmaker, B L Ebert, F Al-Shahrour, R P Hasserjian, E O Scadden, Z Aung, M Matza, M Merkenschlager, C Lin, J M Rommens and D T Scadden: Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature, 464(7290), 852-7 (2010).
148. A Colmone, M Amorim, A L Pontier, S Wang, E Jablonski and D A Sipkins: Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science, 322(5909), 1861-5 (2008).
149. M De Palma, R Mazzieri, L S Politi, F Pucci, E Zonari, G Sitia, S Mazzoleni, D Moi, M A Venneri, S Indraccolo, A Falini, L G Guidotti, R Galli and L Naldini: Tumor-targeted interferon-alpha delivery by Tie2- expressing monocytes inhibits tumor growth and metastasis. Cancer Cell, 14(4), 299-311 (2008).
150. M Ninomiya, A Abe, A Katsumi, J Xu, M Ito, F Arai, T Suda, H Kiyoi, T Kinoshita and T Naoe: Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice. Leukemia, 21(1), 136-42 (2007). (Pubitemid 44921844)
151. T Matsunaga, N Takemoto, T Sato, R Takimoto, I Tanaka, A Fujimi, T Akiyama, H Kuroda, Y Kawano, M Kobune, J Kato, Y Hirayama, S Sakamaki, K Kohda, K Miyake and Y Niitsu: Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med, 9(9), 1158-65 (2003). (Pubitemid 37173700)
152. L Jin, K J Hope, Q Zhai, F Smadja-Joffe and J E Dick: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med, 12(10), 1167-74 (2006). (Pubitemid 44527352)
153. A Avigdor, P Goichberg, S Shivtiel, A Dar, A Peled, S Samira, O Kollet, R Hershkoviz, R Alon, I Hardan, H Ben- Hur, D Naor, A Nagler and T Lapidot: CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood, 103(8), 2981-9 (2004). (Pubitemid 38451670)
154. G E Hannigan, C Leung-Hagesteijn, L Fitz-Gibbon, M G Coppolino, G Radeva, J Filmus, J C Bell and S Dedhar: Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature, 379(6560), 91-6 (1996). (Pubitemid 26008142)
155. Y Tabe, L Jin, Y Tsutsumi-Ishii, Y Xu, T McQueen, W Priebe, G B Mills, A Ohsaka, I Nagaoka, M Andreeff and M Konopleva: Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res, 67(2), 684-94 (2007). (Pubitemid 46192208)
156. A L Muranyi, S Dedhar and D E Hogge: Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors Leuk Res.
157. D P Dialynas, L Shao, G F Billman and J Yu: Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood. Stem Cells, 19(5), 443-52 (2001). (Pubitemid 32900087)
158. M S Kim, C S Lee, J Hur, H J Cho, S I Jun, T Y Kim, S W Lee, J W Suh, K W Park, H Y Lee, H J Kang, D S Lee, G Y Koh, H Nakagami, R Morishita, Y B Park and H S Kim: Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway. Circulation, 120(22), 2240-50 (2009).
159. W C Liles, H E Broxmeyer, E Rodger, B Wood, K Hubel, S Cooper, G Hangoc, G J Bridger, G W Henson, G Calandra and D C Dale: Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood, 102(8), 2728-30 (2003). (Pubitemid 37248839)
160. H E Broxmeyer, C M Orschell, D W Clapp, G Hangoc, S Cooper, P A Plett, W C Liles, X Li, B Graham- Evans, T B Campbell, G Calandra, G Bridger, D C Dale and E F Srour: Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med, 201(8), 1307-18 (2005). (Pubitemid 40629073)
161. B Nervi, P Ramirez, M P Rettig, G L Uy, M S Holt, J K Ritchey, J L Prior, D Piwnica-Worms, G Bridger, T J Ley and J F DiPersio: Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood, 113(24), 6206-14 (2009).
162. Z Zeng, I J Samudio, M Munsell, J An, Z Huang, E Estey, M Andreeff and M Konopleva: Inhibition of CXCR4 with the novel RCP168 peptide overcomes stromamediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther, 5(12), 3113-21 (2006). (Pubitemid 46092053)
163. C Lu and H T Hassan: Human stem cell factorantibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Leuk Res, 30(3), 296-302 (2006). (Pubitemid 43053225)